Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Newmont (NEMCL) Research & Development (2016 - 2025)

Newmont has reported Research & Development over the past 17 years, most recently at $43.0 million for Q4 2025.

  • Quarterly results put Research & Development at $43.0 million for Q4 2025, down 10.42% from a year ago — trailing twelve months through Dec 2025 was $166.0 million (down 15.74% YoY), and the annual figure for FY2025 was $166.0 million, down 15.74%.
  • Research & Development for Q4 2025 was $43.0 million at Newmont, up from $40.0 million in the prior quarter.
  • Over the last five years, Research & Development for NEMCL hit a ceiling of $80.0 million in Q3 2022 and a floor of $31.0 million in Q1 2021.
  • Median Research & Development over the past 5 years was $44.5 million (2022), compared with a mean of $47.3 million.
  • Biggest five-year swings in Research & Development: skyrocketed 100.0% in 2022 and later crashed 33.75% in 2023.
  • Newmont's Research & Development stood at $46.0 million in 2021, then surged by 30.43% to $60.0 million in 2022, then increased by 13.33% to $68.0 million in 2023, then fell by 29.41% to $48.0 million in 2024, then dropped by 10.42% to $43.0 million in 2025.
  • The last three reported values for Research & Development were $43.0 million (Q4 2025), $40.0 million (Q3 2025), and $40.0 million (Q2 2025) per Business Quant data.